Matthew F. Reeves

Matthew F. Reeves

Auto-generated profile, based on publicly available information

Matthew F. Reeves

DuPont Clinic, Washington, DC, USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1996 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
JGJudith B. Grinspan
Judith B. Grinspan
MMMark A. Marchionni
Mark A. Marchionni
MRMatthew Reeves
Matthew Reeves
MCMarkella Coulaloglou
Markella Coulaloglou
SSSteven S. Scherer
Steven S. Scherer
Programmed cell death during development resulting from the lack of appropriate survival factors has been demonstrated in both neurons and oligodendrocytes and occurs mostly in the form of apoptosis. We now demonstrate that Schwann cells in the rat sciatic nerve undergo apoptosis during early postnatal development and that the amount of apoptosis is markedly increased by axotomy. The apoptotic Schwann cells express the low-affinity nerve growth factor receptor but not myelin-related proteins, indicating that they are in the premyelinating state. Apoptosis resulting from normal development or from axotomy can be inhibited markedly by exogenous neuregulin. Consistent with this, the neuregulin receptor componentserbB2 anderbB3 are expressed and phosphorylated in developing sciatic nerve. These data suggest that Schwann cell number in developing peripheral nerve is regulated by apoptosis through competition for axonally derived neuregulin.

1 November 2010 in Obstetrics & Gynecology
Verified
Journal Article
Closed access
BCBeatrice A. Chen
Beatrice A. Chen
MRMatthew F. Reeves
Matthew F. Reeves
JHJennifer L. Hayes
Jennifer L. Hayes
HHHeather L. Hohmann
Heather L. Hohmann
LPLisa K. Perriera
Lisa K. Perriera
MCMitchell D. Creinin
Mitchell D. Creinin
OBJECTIVE: To estimate whether 6-month use of the levonorgestrel-releasing intrauterine device (IUD) would be higher when insertion occurred within 10 minutes of placental delivery compared with 6–8 weeks postpartum. METHODS: We enrolled pregnant women planning vaginal deliveries and desiring a postpartum levonorgestrel-releasing IUD. Patients were randomly assigned when admitted in labor to postplacental or delayed IUD insertion. The women followed up in person at 6–8 weeks and 6 months and were contacted by telephone at 3 months. Women were ineligible for a study IUD postenrollment for intrapartum events including infection, hemorrhage, and cesarean delivery; these women were contacted by phone at 3 and 6 months. Expelled IUDs were replaced per patient preference. RESULTS: Successful IUD placement occurred in 50 of 51 participants (98.0%) and 46 of 51 participants (90.2%) in the postplacental and delayed groups, respectively (P=.2). Expulsion within 6 months occurred in 12 of 50 (24.0%; 95% confidence interval [CI], 13.1–38.2) and two of 46 (4.4%; 95% CI 0.5–14.8) participants, respectively (P=.008). Intrauterine device use at 6 months was 43 of 51 (84.3%; 95% CI 71.4–93.0) and 39 of 51 (76.5%; 95% CI 62.5–87.2), respectively (P=.32). For ineligible patients, only 11 of 41 (26.8%) women were using IUDs at 6 months and two (4.9%) had become pregnant. CONCLUSION: Intrauterine device use 6 months after delivery is similar in women who have postpartum or scheduled delayed IUD placement through a study after replacement of expelled IUDs. Expulsions are significantly higher with postplacental compared with delayed IUD placement. Women asked to follow up with their own health care providers for delayed insertion are significantly less likely to receive an IUD. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov , www.clinicaltrials.gov , NCT00476021. LEVEL OF EVIDENCE: I

9 June 2011 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
PBPaula H. Bednarek
Paula H. Bednarek
MCMitchell D. Creinin
Mitchell D. Creinin
MRMatthew F. Reeves
Matthew F. Reeves
CCCarrie Cwiak
Carrie Cwiak
EEEve Espey
Eve Espey
JJJeffrey T. Jensen
Jeffrey T. Jensen
Intrauterine devices (IUDs) provide highly effective, reversible, long-term contraception that is appropriate for many women after first-trimester uterine aspiration. However, the effects of immediate versus delayed IUD insertion after uterine aspiration on rates of complications and IUD use are uncertain.

1 August 2008 in Contraception
Verified
Journal Article
Closed access
SGSuzan Goodman
Suzan Goodman
SHSarah K. Hendlish
Sarah K. Hendlish
MRMatthew F. Reeves
Matthew F. Reeves
AFAnne Foster-Rosales
Anne Foster-Rosales

1 April 2011 in Contraception
Verified
Journal Article
Closed access
SASharon L. Achilles
Sharon L. Achilles
MRMatthew F. Reeves
Matthew F. Reeves

1 February 2010 in Contraception
Verified
Journal Article
Closed access
LPLisa K. Perriera
Lisa K. Perriera
MRMatthew F. Reeves
Matthew F. Reeves
BCBeatrice A. Chen
Beatrice A. Chen
HHHeather L. Hohmann
Heather L. Hohmann
JHJennifer Hayes
Jennifer Hayes
MCMitchell D. Creinin
Mitchell D. Creinin